Mostrar el registro sencillo del ítem

dc.contributor.author
Rudzinski, Marcelo Nicolas  
dc.contributor.author
Argüelles, Carina  
dc.contributor.author
Couto, Cristóbal  
dc.contributor.author
Oubiña, Jose Raul  
dc.contributor.author
Reina, Silvia Lorena  
dc.date.available
2022-05-06T13:54:39Z  
dc.date.issued
2018-08  
dc.identifier.citation
Rudzinski, Marcelo Nicolas; Argüelles, Carina; Couto, Cristóbal; Oubiña, Jose Raul; Reina, Silvia Lorena; Immune Mediators against Toxoplasma Gondii during Reactivation of Toxoplasmic Retinochoroiditis; Taylor & Francis Ltd; Ocular Immunology And Inflammation; 27; 6; 8-2018; 949-957  
dc.identifier.issn
0927-3948  
dc.identifier.uri
http://hdl.handle.net/11336/156779  
dc.description.abstract
Purpose: The purpose of this article is to analyze possible associations between systemic and ocular cytokine levels and specific clinical ophthalmologic signs from patients with a reactivation of toxoplasmic retinochoroiditis (RTR). Methods: A total of 18 patients with an active RTR episode, 8 patients with inactive scars, and 14 control patients were included in the study. Serum samples and aqueous humor (AH) samples were analyzed for IFN (interferon)-ã, interleukin (IL)-10, and IL-6 levels by ELISA. Inflammation grade, location, and size of the retinochoroidal active lesion, sampling time, and time to resolution were recorded. Results: A significantly negative correlation between AH and serum levels of IFN-ã was detected (p < 0.05). Patients with an AH IFN-ã/IL-10 ratio lower than 1 were associated with the longest time to resolution and/or severe complications. Conclusion: Serum IFN-ã levels may be used as a prognostic marker for both time to resolution and the development of possible severe complications during a given RTR episode.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Taylor & Francis Ltd  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
ARGENTINA  
dc.subject
IMMUNE RESPONSE  
dc.subject
RETINOCHOROIDITIS  
dc.subject
TOXOPLASMOSIS  
dc.subject.classification
Oftalmología  
dc.subject.classification
Medicina Clínica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.subject.classification
Inmunología  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Immune Mediators against Toxoplasma Gondii during Reactivation of Toxoplasmic Retinochoroiditis  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2022-04-20T14:49:36Z  
dc.journal.volume
27  
dc.journal.number
6  
dc.journal.pagination
949-957  
dc.journal.pais
Alemania  
dc.journal.ciudad
Tubingen  
dc.description.fil
Fil: Rudzinski, Marcelo Nicolas. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Catolica de Las Misiones; Argentina  
dc.description.fil
Fil: Argüelles, Carina. Universidad Catolica de Las Misiones; Argentina  
dc.description.fil
Fil: Couto, Cristóbal. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina  
dc.description.fil
Fil: Oubiña, Jose Raul. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones en Microbiología y Parasitología Médica. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones en Microbiología y Parasitología Médica; Argentina  
dc.description.fil
Fil: Reina, Silvia Lorena. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Catolica de Las Misiones; Argentina  
dc.journal.title
Ocular Immunology And Inflammation  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.tandfonline.com/doi/full/10.1080/09273948.2018.1499940  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1080/09273948.2018.1499940